Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

GlaxoSmithKline Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (243)
ARTG (107)
Australian public assessment report (AusPar) (41)
Prescription medicine registration (20)
Designation or determination (5)
Prescription medicine evaluation (4)
Prescription medicine decision summary (3)
Face mask cancellation (1)

Date

2025 (25)
2024 (13)
2023 (18)
2022 (61)
2021 (12)
2020 (59)
2019 (30)
2018 (27)
2017 (24)
2016 (11)
2015 (49)
2014 (21)
2013 (9)
2012 (6)
2011 (4)
2010 (7)
2009 (3)
2008 (6)
2007 (5)
2006 (3)
2005 (4)
2004 (1)
2003 (3)
2002 (1)
2001 (1)
2000 (3)
1999 (1)
1998 (5)
1997 (4)
1995 (1)
1991 (6)

Search

Sponsor content

424 result(s) found, displaying 271 to 280

AIRZATE ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack (208190)

7 May 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AIRZATE ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack.
PAVTIDE ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack (208202)

7 May 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PAVTIDE ACCUHALER 500/50 fluticasone propionate 500 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack.
AIRZATE ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack (208189)

7 May 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AIRZATE ACCUHALER 250/50 fluticasone propionate 250 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack.
BREO ELLIPTA fluticasone furoate 100 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation (199748)

17 April 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BREO ELLIPTA fluticasone furoate 100 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation.
BREO ELLIPTA fluticasone furoate 200 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation (199747)

17 April 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BREO ELLIPTA fluticasone furoate 200 microgram / vilanterol (as trifenatate) 25 microgram powder for inhalation.
AusPAR: Mepolizumab (rch)

5 April 2017

Australian public assessment report (AusPar)

Australian Public Assessment Report for mepolizumab (rch)
STIEPROX LIQUID ciclopirox olamine 15mg/g shampoo bottle Cancelled under s30(1)(c) of the Act

28 March 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
STIEPROX LIQUID ciclopirox olamine 15mg/g shampoo bottle Cancelled under s30(1)(c)

28 March 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
BECONASE AQ beclometasone dipropionate 0.5mg/mL (50 microgram/actuation) (as monohydrate) aqueous nasal spray Cancelled under s30(1)(c) of the Act

15 March 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
HYDROFORM 1% clioquinol / hydrocortisone cream tube Cancelled under s30(1)(c) of the Act

6 March 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd

Pages

First page
Previous page
…
Page 24
Page 25
Page 26
Page 27
Current page 28
Page 29
Page 30
Page 31
Page 32
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.